MENU
HQL
ETF ticker: NYSE
PRICE
CHANGE
NET ASSETS
abrdn Life Sciences Investors (HQL) Ownership - Who owns abrdn Life Sciences Investors?
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company... Show more
Profile
Category
Health
Address
2 Liberty Square9th FloorBoston
Phone
N/A
Web
https://www.teklacap.com/funds/hql/fund/fund-information/
Details
Group
Alternative Funds
Category
Unknown
Net Assets
422958240.00
Fund Existence
about 33 years
Turnover
46.00
Capitalization
N/A
Yield
4.38
Total Expense Ratio
1.35
Investment Style
N/A
Risk (Beta)
0.62
Fundamentals
HQL
Net Assets
423M
Yield
4.38
Fund Existence
about 33 years
Total Expense Ratio
1.35
Turnover
46.00
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
0.62
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
1.66
Assets in Top Ten Holdings
228M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
423M
Fund Type
ClosedEnd
Index Fund
No
Management Fee
0.98
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
136.00
Number of Net Holdings
136.00
Number of Short Holdings
N/A
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
34.52%
Gain YTD
6.830
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Category Unknown
Profile
Fundamentals
Details
Category
Health
Address
2 Liberty Square9th FloorBoston
Phone
N/A
Web
https://www.teklacap.com/funds/hql/fund/fund-information/